NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
| | | | | |

NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence

In 2006, the National Cancer Institute (NCI) launched the TAILORx trial to determine whether gene expression patterns in…

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
| | | | | |

World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.

In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…